InMode Ltd.

INMD

Equity

ISIN IL0011595993 / Valor 49023508

NASDAQ (2025-11-17)

USD 13.91-1.83%

InMode Ltd.
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

InMode Ltd. is a global provider of medical technologies specializing in radio-frequency (RF) based platforms for minimally-invasive and surgical procedures in various specialties such as plastic surgery, gynecology, dermatology, ENT’s, and ophthalmology. Founded in 2008, InMode has developed a comprehensive line of platforms to address a multi-billion dollar market opportunity. The company's leadership team includes Dr. Michael Kreindel, a co-founder and Chief Technology Officer, who is known for his expertise in aesthetics treatments, and Dr. Spero Theodorou, the Chief Medical Officer, with a background in plastic and reconstructive surgery. Alon Yaari serves as the Chief Operations Officer overseeing manufacturing, supply chain, engineering, and logistics.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Performance

GAAP revenues for Q1 2025 were $77.9 million, reflecting a 3% decline from $80.3 million in Q1 2024. Revenues from consumables and services decreased by 10% to $20.2 million compared to the previous year.

Operating Income

InMode Ltd. achieved a GAAP operating income of $15.6 million and a non-GAAP operating income of $18.1 million in Q1 2025, both showing a decrease compared to Q1 2024.

Cash Position

As of March 31, 2025, InMode maintained a robust total cash position of $512.9 million, encompassing cash and cash equivalents, marketable securities, and short-term bank deposits.

Share Repurchase Program

The company completed a share repurchase of 6.95 million ordinary shares in April 2025, returning $127 million of capital to shareholders year-to-date through its ongoing share repurchase initiative.

Financial Outlook

For the full year 2025, InMode expects revenues between $395 to $405 million and non-GAAP gross margins between 78% and 80%. The company anticipates continued pressure on operating margins and the impact of U.S. tariffs on gross margins.

Summarized from source with an LLMView Source

Key figures

-22.8%1Y

-62.3%3Y

-67.4%5Y

Performance

39.7%1Y

47.4%3Y

63.0%5Y

Volatility